Follow up Discussion with Claude about Dermpedia Case 3 from 6.16.26 (Dr Zembowicz asked me to share this with the group)

What is the relationship of Atrophy Blanche and Livedoid Vasculopathy?

Atrophie Blanche (AB) and Livedoid Vasculopathy (LV) are closely related dermatological conditions — in fact, Atrophie Blanche is considered the end-stage scar of Livedoid Vasculopathy, not a separate disease.

Their Relationship

Livedoid Vasculopathy (LV) is the active disease process characterized by:

• Recurrent thrombosis of small dermal blood vessels (primarily in the lower legs and ankles) • Painful purpuric papules and ulcerations • A chronic, relapsing course • Underlying hypercoagulable states in many patients

Atrophie Blanche (AB) is the resulting scar that forms after LV ulcerations heal, characterized by:

• Porcelain-white, stellate (star-shaped) atrophic scars • Surrounded by hyperpigmentation and telangiectasias • Located on the lower legs and dorsal feet • Representing healed infarcts from prior thrombotic episodes

Key Points

• AB is a clinical sign, not a diagnosis — it is the morphological endpoint/sequela of LV. • Historically, AB was thought to be a primary condition, but it is now understood to be a non-specific scar that can result from LV or other conditions causing dermal vascular occlusion (e.g., antiphospholipid syndrome, sickle cell disease, chronic venous insufficiency). • The terms were once used interchangeably in older literature, which caused some confusion. • A patient with LV will eventually develop AB scars if the thrombotic episodes recur and heal repeatedly.

In Summary

|Feature         |Livedoid Vasculopathy  |Atrophie Blanche             ||----------------|--------------------

That is how I think of it.

Great minds think alike! It’s a conceptually clean way to understand them — one is the storm, the other is the damage left behind. The historical confusion from older literature using the terms interchangeably didn’t help, but the modern framework of LV as the active thrombotic process and AB as its scar makes the pathophysiology much more intuitive.

Is there a particular aspect of LV/AB you’re exploring — management, workup for hypercoagulable states, or something else?

It was a case for diagnosis and discussion on Dermpedia today.

That’s a great teaching case topic — LV is one of those conditions that can be genuinely tricky to diagnose, especially early on when it just looks like painful purpura or ulcers that aren’t healing well. It’s easy to misattribute it to venous insufficiency or vasculitis initially.

Did the Dermpedia case highlight anything particular — like an interesting workup finding, an unusual presentation, or a specific treatment approach they featured?

The person who contributed the case for consultation noted that there has been clinical suspicion of pyoderma gangrenosum and bx was done with a question of Atrophie Blanche by the clinician. Histologically, there was a hyalinizing and fibrinoid dermal vasculopathy.

That’s a classic and clinically important diagnostic dilemma! PG vs LV is a well-known pitfall, and the case illustrates exactly why histopathology is so critical here.

Why PG Gets Suspected

• Both present with painful ulcers on the lower legs that seem recalcitrant

• PG is often in the differential when ulcers don’t heal as expected

• The “pathergy” phenomenon in PG can even be mistakenly triggered by biopsy attempts

Why Histology Resolves It

The findings you described are telling:

• Hyalinizing/fibrinoid dermal vasculopathy — thickened, eosinophilic vessel walls with intraluminal fibrin thrombi — is the hallmark of LV

• PG histology shows a neutrophilic infiltrate with dermal necrosis, without the vascular occlusive/fibrinoid changes

• The absence of a true vasculitis (no leukocytoclasia, no vessel wall destruction by inflammation) further supports LV over an inflammatory process

The Clinical Lesson

This case underscores a key teaching point: PG is a diagnosis of exclusion, and before committing to it (and potentially immunosuppressing a patient), ruling out LV with biopsy is essential — since the treatments are essentially opposite in direction (immunosuppression vs. anticoagulation/antiplatelet therapy).

The clinician’s instinct to also raise atrophie blanche was astute — recognizing the scarring component pointed toward the thrombotic etiology. Was there any discussion of the patient’s hypercoagulable workup?

No

That would have been an interesting addition to the discussion — since identifying an underlying hypercoagulable state (antiphospholipid antibodies, factor V Leiden, MTHFR mutations, protein C/S deficiency, etc.) can directly guide long-term management, particularly around anticoagulation decisions.

But even without it, the case as presented is a great teaching example just on the clinicopathological correlation alone — the journey from clinical suspicion of PG, to the biopsy, to landing on LV based on the fibrinoid vasculopathy is a very instructive diagnostic narrative.

Dermpedia cases like that are valuable precisely because they reflect real-world diagnostic uncertainty rather than a textbook-perfect presentation.